Navigation Links
Mindray Medical International Announces Second Quarter 2008 Results
Date:9/3/2008

ings per

share 112,122,314 113,800,224 111,920,859 113,399,242

Non-GAAP operating

income 23,741 39,998 42,117 70,791

Non-GAAP operating

margin 32.5% 27.5% 33.0% 30.4%

Expense/Amortization

of acquired

intangible assets (613) (9,833) (1,220) (10,490)

Share-based

compensation (1,867) (2,350) (3,577) (4,585)

GAAP operating income 21,260 27,816 37,320 55,716

GAAP operating margin 29.1% 19.1% 29.3% 23.9%

Non-GAAP gross profit 41,597 79,895 72,811 130,089

Non-GAAP gross margin 57.0% 54.8% 57.1% 55.8%

Expense/Amortization

of acquired

intangible assets (613) (2,813) (1,220) (3,470)

Share-based

compensation (56) (111) (101) (221)

GAAP gross profit 40,928 76,972 71,491 126,398

GAAP gross margin 56.0% 52.8% 56.1% 54.2%


'/>"/>
SOURCE Mindray Medical International Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
2. Mindray Announces Appointment of Dr. Jixun Lin as Independent Director
3. Mindray Medical International Announces Third Quarter 2007 Results
4. Mindray to Acquire Datascopes Patient Monitoring Business for US$202 million
5. Mindray Medical International Announces First Quarter 2008 Results
6. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
7. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
8. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
9. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
10. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
11. BioMS Medical announces its intention to renew a normal course issuer bid
Post Your Comments:
*Name:
*Comment:
*Email: